Exemestane

Licensed by Pfizer Catalog No.S1196 Synonyms: FCE24304, PNU155971

Exemestane Chemical Structure

Molecular Weight(MW): 296.4

Exemestane is an aromatase inhibitor, inhibits human placental and rat ovarian aromatase with IC50 of 30 nM and 40 nM, respectively.

Size Price Stock Quantity  
In DMSO USD 90 In stock
USD 70 In stock
USD 150 In stock
USD 270 In stock
USD 470 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Cited by 5 Publications

2 Customer Reviews

  • Effect of exemestane on phosphatidylserine exposure. A. Original histogram of annexin-V-binding of erythrocytes following exposure for 48 hours to Ringer solution without (grey area) and with (black line) presence of 40 µg/ml exemestane. B. Arithmetic means ± SEM (n = 24) of erythrocyte annexin-V-binding following incubation for 48 hours to Ringer solution without (white bar) or with (black bars) exemestane (10-40 µg/ml). For comparison, the effect of the solvent DMSO is shown (grey bar). **(p<0.01),***(p<0.001) indicates significant difference from the absence of exemestane (ANOVA).

    Cell Physiol Biochem, 2017, 42(1):1-12. Exemestane purchased from Selleck.

    Expression of ER, PR, Bcl-2, HER receptors and CYP19A1 mRNA in MCF-7 and AI-resistant cell lines. (A) Western blot analysis of lysates from MCF-7 cells grown with 10% NCS+10-7 M testosterone (MCF-7) and LetR-1, LetR-3, ExeR-1 and ExeR-3 grown in their standard growth medium with 10-6 M letrozole and 10-7 M exemestane, respectively. β-actin and Hsp70 were used as loading controls. (B) Western blot analysis of lysates from MCF-7, LetR-1 and ExeR-1 cells grown for five days in 10% NCS (C) or 10% NCS + 10-12 M estradiol (E2), 10% NCS + 10-7 M testosterone (T), 10% NCS + 10-7 M testosterone + 10-6 M letrozole (T + L), 10% NCS + 10-7 M testosterone + 10-7 M exemestane (T+E). LetR-1 and ExeR-1 cells were withdrawn from testosterone and their respective AI one week before onset of experiment. β-actin was used as loading control. (C) CYP19A1 mRNA level in MCF-7 cells grown with 10% NCS + 10-7 M testosterone for five days and AI-resistant cell lines grown in their standard medium determined by quantitative RT-PCR

    Int J Oncol, 2015, 46(4):1481-90.. Exemestane purchased from Selleck.

Purity & Quality Control

Choose Selective Aromatase Inhibitors

Biological Activity

Description Exemestane is an aromatase inhibitor, inhibits human placental and rat ovarian aromatase with IC50 of 30 nM and 40 nM, respectively.
Features 17-hydroexemestane is the principal metabolite of Exemestane.
Targets
Aromatase (human) [1] Aromatase (rat) [1]
30 nM 40 nM
In vitro

Exemestane competitively inhibits and time-dependently inactivates of human placental aromatase with Ki of 4.3 nM. Exemestane displaces [3H]DHT from rat prostate androgen receptor with IC50 of 0.9 μM. [1] Exemestane (1 μM) increases alkaline phosphatase activity in hFOB and Saos-2 cells and induces the expression of MYBL2, OSTM1, HOXD11, ADCYAP1R1, and glypican 2 in hFOB cells. [2] Exemestane causes aromatase degradation in a dose-responsive manner in MCF-7aro cells. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
human MCF7a cells NXLlV2hyS3m2b4TvfIlkcXS7IHHzd4F6 NGm4OXgyOCCmYYnz NH65T|lEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBOS0Z5YTDj[YxteyCneIDy[ZN{cW6pIGTleE1w\mZvM3LleIFJW0RzLVHyc40h[XO|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBVW1Rvc4TpcZVt[XSnZDDj[YxtKHC{b3zp[oVz[XSrb36gcYVie3W{ZXSgZYZ1\XJiMUCg[IF6eyxiRVO1NF02NjZibl2= MWeyNlk2OTB5NB?=
human MCF7 cells NV7HSWo5S3m2b4TvfIlkcXS7IHHzd4F6 MnjKNVAhfG9iMUWg{txO MmLFN{03KGSjeYO= M3zYN2N6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJJBt[WOnboThcEBucWO{b4PvcYUh[XKxbXH0ZZNmKGW6cILld5NqdmdiaIXtZY4hVUOINzDj[YxteyCjc4Pld5Nm\CCjczDy[YR2[3Srb36gbY4h[2WubDD2bYFjcWyrdImgZZQhOTBidH:gNVUhfU1iYX\0[ZIhOyC2bzC2JIRigXNiYomgUXRVKGG|c3H5JIlvKHC{ZYPlcoNmKG:oIHXzeJJi\GmxbB?= MkThNlUzPzdyNk[=

... Click to View More Cell Line Experimental Data

In vivo Exemestane increases lumbar spine BMD by 14.0% in OVX rats at dose of 100 mg/kg. Exemestane (100 mg/kg) and 17-hydroexemestane (20 mg/kg) significantly reduces an ovariectomy-induced increase in serum pyridinoline and serum osteocalcin in rats and causes significant reductions of serum cholesterol and low-density lipoprotein cholesterol inOVX rats. [4] Exemestane (20 mg/kg/day s.c.) induces 26% complete (CR) and 18% partial (PR) tumor regressions in rats with 7,12-dimethylbenzanthracene (DMBA)-induced mammary tumors. [5]

Protocol

Kinase Assay:[1]
+ Expand

Assays with human placental aromatase:

Microsomes are prepared from human placenta and stored at -80℃. The rate of aromatization is determined by measuring the tritiated water released from [1β-3H]A. The assay is carried out in a final volume of 1 mL, in 10 mM phosphate buffer, pH 7.5, containing 100 mM KCl, 1 mM EDTA, 1 mM dithiothreitol, 100 μM NADPH, the enzyme preparation and the appropriate concentrations of Exemestane (in duplicate) and the substrate. After a 10 min incubation at 37 ℃, the assay is terminated by the addition of 4 mL cold chloroform. The acqueous phase is treated with a charcoal suspension, the supernatant is removed and counted for radioactivity by liquid scintillation in Rialuma. For the determination of the IC50 values, various concentrations of Exemestane are incubated with 20 μg of microsomal protein, in the presence of a fixed amount (50 nM) of [3H]A.
Cell Research:[2]
+ Expand
  • Cell lines: hFOB cells
  • Concentrations: 1 μM
  • Incubation Time: 24 hours
  • Method: hFOB is treated with steroids and Exemestane for 24 hours, when specimens are harvested and evaluated for cell proliferation using the WST-8 method. Optical densities (OD, 450 nm) are evaluated using a SpectraMax 190 microplate reader and Softmax Pro 4.3 microplate analysis software. The status of proliferation (%) is calculated according to the following equation: (cell OD value after test materials treated /vehicle control cell OD value)× 10
    (Only for Reference)
Animal Research:[4]
+ Expand
  • Animal Models: estrogen-deficient ovariectomized (OVX) rats
  • Formulation: saline
  • Dosages: 100 mg/kg
  • Administration: Intramuscular injection
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 54 mg/mL (182.18 mM)
Ethanol 15 mg/mL (50.6 mM)
Water Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 296.4
Formula

C20H24O2

CAS No. 107868-30-4
Storage powder
in solvent
Synonyms FCE24304, PNU155971

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT03874325 Recruiting Breast Cancer|Hormone Receptor Positive Tumor H. Lee Moffitt Cancer Center and Research Institute|AstraZeneca March 11 2019 Phase 2
NCT03874325 Recruiting Breast Cancer|Hormone Receptor Positive Tumor H. Lee Moffitt Cancer Center and Research Institute|AstraZeneca March 11 2019 Phase 2
NCT03691493 Recruiting Anatomic Stage IV Breast Cancer AJCC v8|Estrogen Receptor Positive|HER2/Neu Negative|Metastatic Breast Carcinoma|Metastatic Malignant Neoplasm in the Bone|Progesterone Receptor Positive|Prognostic Stage IV Breast Cancer AJCC v8 Emory University|Pfizer February 8 2019 Phase 2
NCT03691493 Recruiting Anatomic Stage IV Breast Cancer AJCC v8|Estrogen Receptor Positive|HER2/Neu Negative|Metastatic Breast Carcinoma|Metastatic Malignant Neoplasm in the Bone|Progesterone Receptor Positive|Prognostic Stage IV Breast Cancer AJCC v8 Emory University|Pfizer February 8 2019 Phase 2
NCT03554044 Not yet recruiting Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Estrogen Receptor Positive|HER2/Neu Negative|Invasive Breast Carcinoma|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8|Recurrent Breast Carcinoma University of California San Francisco|Amgen December 11 2018 Phase 1
NCT03554044 Not yet recruiting Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Estrogen Receptor Positive|HER2/Neu Negative|Invasive Breast Carcinoma|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8|Recurrent Breast Carcinoma University of California San Francisco|Amgen December 11 2018 Phase 1

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Aromatase Signaling Pathway Map

Related Aromatase Products0

Tags: buy Exemestane | Exemestane supplier | purchase Exemestane | Exemestane cost | Exemestane manufacturer | order Exemestane | Exemestane distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID